{"id":"https://openalex.org/W7225617423","doi":"https://doi.org/10.1080/20415990.2026.2755238","title":"Investigation of astaxanthin-loaded hollow gold nanoparticles in mitigating the EAE mice model of multiple sclerosis","display_name":"Investigation of astaxanthin-loaded hollow gold nanoparticles in mitigating the EAE mice model of multiple sclerosis","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225617423","doi":"https://doi.org/10.1080/20415990.2026.2755238","pmid":"https://pubmed.ncbi.nlm.nih.gov/43001837"},"language":"en","primary_location":{"id":"doi:10.1080/20415990.2026.2755238","doi":"https://doi.org/10.1080/20415990.2026.2755238","is_oa":false,"landing_page_url":"https://doi.org/10.1080/20415990.2026.2755238","pdf_url":null,"source":{"id":"https://openalex.org/S89829989","display_name":"Therapeutic Delivery","issn_l":"2041-5990","issn":["2041-5990","2041-6008"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Delivery","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5122498176","display_name":"Aishwarya Mhatre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098333","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/011npsm46","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210098333"]},{"id":"https://openalex.org/I4210103783","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/025qtp564","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210103783"]},{"id":"https://openalex.org/I4210146715","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/040dgqr26","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210146715"]},{"id":"https://openalex.org/I4210152674","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/0418yqg16","country_code":"IN","type":"government","lineage":["https://openalex.org/I4210152674"]},{"id":"https://openalex.org/I4210154014","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/04p9b6182","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210154014"]},{"id":"https://openalex.org/I4210161501","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/04t67vr60","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210161501"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Aishwarya Mhatre","raw_affiliation_strings":["National Institute of Pharmaceutical Education and Research"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute of Pharmaceutical Education and Research","institution_ids":["https://openalex.org/I4210098333","https://openalex.org/I4210103783","https://openalex.org/I4210146715","https://openalex.org/I4210152674","https://openalex.org/I4210154014","https://openalex.org/I4210161501"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102702212","display_name":"S.N.H. Naqvi","orcid":"https://orcid.org/0009-0007-9156-2189","observed_orcids":["https://orcid.org/0009-0007-9156-2189"]},"institutions":[{"id":"https://openalex.org/I4210098333","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/011npsm46","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210098333"]},{"id":"https://openalex.org/I4210103783","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/025qtp564","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210103783"]},{"id":"https://openalex.org/I4210146715","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/040dgqr26","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210146715"]},{"id":"https://openalex.org/I4210152674","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/0418yqg16","country_code":"IN","type":"government","lineage":["https://openalex.org/I4210152674"]},{"id":"https://openalex.org/I4210154014","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/04p9b6182","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210154014"]},{"id":"https://openalex.org/I4210161501","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/04t67vr60","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210161501"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Jasleen Kaur","raw_affiliation_strings":["National Institute of Pharmaceutical Education and Research"],"raw_orcid":"https://orcid.org/0009-0007-9156-2189","affiliations":[{"raw_affiliation_string":"National Institute of Pharmaceutical Education and Research","institution_ids":["https://openalex.org/I4210098333","https://openalex.org/I4210103783","https://openalex.org/I4210146715","https://openalex.org/I4210152674","https://openalex.org/I4210154014","https://openalex.org/I4210161501"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042928471","display_name":"Saba Naqvi","orcid":"https://orcid.org/0000-0001-6591-790X","observed_orcids":["https://orcid.org/0000-0001-6591-790X"]},"institutions":[{"id":"https://openalex.org/I4210098333","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/011npsm46","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210098333"]},{"id":"https://openalex.org/I4210103783","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/025qtp564","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210103783"]},{"id":"https://openalex.org/I4210146715","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/040dgqr26","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210146715"]},{"id":"https://openalex.org/I4210152674","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/0418yqg16","country_code":"IN","type":"government","lineage":["https://openalex.org/I4210152674"]},{"id":"https://openalex.org/I4210154014","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/04p9b6182","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210154014"]},{"id":"https://openalex.org/I4210161501","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/04t67vr60","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210161501"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Saba Naqvi","raw_affiliation_strings":["National Institute of Pharmaceutical Education and Research"],"raw_orcid":"https://orcid.org/0000-0001-6591-790X","affiliations":[{"raw_affiliation_string":"National Institute of Pharmaceutical Education and Research","institution_ids":["https://openalex.org/I4210098333","https://openalex.org/I4210103783","https://openalex.org/I4210146715","https://openalex.org/I4210152674","https://openalex.org/I4210154014","https://openalex.org/I4210161501"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5042928471"],"corresponding_institution_ids":["https://openalex.org/I4210098333","https://openalex.org/I4210103783","https://openalex.org/I4210146715","https://openalex.org/I4210152674","https://openalex.org/I4210154014","https://openalex.org/I4210161501"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"1","last_page":"15"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.8003000020980835,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.8003000020980835,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.1868000030517578,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/astaxanthin","display_name":"astaxanthin","score":0.9900000095367432},{"id":"https://openalex.org/keywords/hollow-gold-nanoparticles","display_name":"hollow gold nanoparticles","score":0.9819999933242798},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9490000009536743},{"id":"https://openalex.org/keywords/experimental-autoimmune-encephalomyelitis","display_name":"experimental autoimmune encephalomyelitis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-delivery-to-the-brain","display_name":"brain drug delivery","score":0.8569999933242798},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.7979999780654907},{"id":"https://openalex.org/keywords/motor-impairment","display_name":"motor impairment","score":0.9459999799728394},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9160000085830688},{"id":"https://openalex.org/keywords/nanoparticle-drug-loading","display_name":"nanoparticle drug loading","score":0.5239999890327454}],"concepts":[{"id":"https://openalex.org/C2778486448","wikidata":"https://www.wikidata.org/wiki/Q494066","display_name":"Experimental autoimmune encephalomyelitis","level":3,"score":0.8745999932289124},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.8608999848365784},{"id":"https://openalex.org/C104819515","wikidata":"https://www.wikidata.org/wiki/Q900961","display_name":"Colloidal gold","level":3,"score":0.7886000275611877},{"id":"https://openalex.org/C2779075594","wikidata":"https://www.wikidata.org/wiki/Q8084905","display_name":"Autoimmune disease","level":3,"score":0.48809999227523804},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.4832000136375427},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4390000104904175},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.4153999984264374},{"id":"https://openalex.org/C2777899865","wikidata":"https://www.wikidata.org/wiki/Q1634879","display_name":"Encephalomyelitis","level":3,"score":0.375},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.3578999936580658},{"id":"https://openalex.org/C2780962900","wikidata":"https://www.wikidata.org/wiki/Q413740","display_name":"Astaxanthin","level":3,"score":0.35749998688697815},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3553999960422516},{"id":"https://openalex.org/C40993552","wikidata":"https://www.wikidata.org/wiki/Q514654","display_name":"Gold standard (test)","level":2,"score":0.34769999980926514},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.33640000224113464},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.298799991607666},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.29089999198913574},{"id":"https://openalex.org/C127445965","wikidata":"https://www.wikidata.org/wiki/Q2518429","display_name":"Nanotoxicology","level":3,"score":0.28610000014305115},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.26930001378059387},{"id":"https://openalex.org/C2910496842","wikidata":"https://www.wikidata.org/wiki/Q897","display_name":"Gold Compounds","level":2,"score":0.25369998812675476},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.25099998712539673},{"id":"https://openalex.org/C2780130043","wikidata":"https://www.wikidata.org/wiki/Q192360","display_name":"Autoimmunity","level":3,"score":0.2506999969482422}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1080/20415990.2026.2755238","doi":"https://doi.org/10.1080/20415990.2026.2755238","is_oa":false,"landing_page_url":"https://doi.org/10.1080/20415990.2026.2755238","pdf_url":null,"source":{"id":"https://openalex.org/S89829989","display_name":"Therapeutic Delivery","issn_l":"2041-5990","issn":["2041-5990","2041-6008"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Delivery","raw_type":"journal-article"},{"id":"pmid:43001837","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/43001837","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic delivery","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W295908243","https://openalex.org/W1502642867","https://openalex.org/W1580470274","https://openalex.org/W1607206274","https://openalex.org/W1965887065","https://openalex.org/W1995199032","https://openalex.org/W2060345011","https://openalex.org/W2063201358","https://openalex.org/W2063962692","https://openalex.org/W2074202178","https://openalex.org/W2077628984","https://openalex.org/W2180696344","https://openalex.org/W2555603121","https://openalex.org/W2587637294","https://openalex.org/W2752591735","https://openalex.org/W2790783330","https://openalex.org/W2799278974","https://openalex.org/W2896365355","https://openalex.org/W2943993219","https://openalex.org/W3004892697","https://openalex.org/W3018471127","https://openalex.org/W3024122904","https://openalex.org/W3025526823","https://openalex.org/W3029127089","https://openalex.org/W3158394864","https://openalex.org/W3162012128","https://openalex.org/W3204300536","https://openalex.org/W3209766905","https://openalex.org/W4200245243","https://openalex.org/W4213418642","https://openalex.org/W4290613746","https://openalex.org/W4293065232","https://openalex.org/W4295438129","https://openalex.org/W4319662009","https://openalex.org/W4385620544","https://openalex.org/W4386741926","https://openalex.org/W4389684079","https://openalex.org/W4403147784","https://openalex.org/W4407583867","https://openalex.org/W6902611776"],"related_works":["https://openalex.org/W2790783330","https://openalex.org/W4289711048","https://openalex.org/W2067754676","https://openalex.org/W2938380255","https://openalex.org/W4300688605","https://openalex.org/W3131083127","https://openalex.org/W3018471127","https://openalex.org/W3124732647","https://openalex.org/W7204238641","https://openalex.org/W7213221958"],"abstract_inverted_index":{"AIMS:":[0],"Multiple":[1],"sclerosis":[2,86],"(MS)":[3],"is":[4,25],"a":[5,26,104],"progressive":[6],"neurological":[7,172],"autoimmune":[8,79],"disorder":[9],"that":[10,126,138],"affects":[11],"the":[12,19,41,60,63,68,109,132,155,163,175],"central":[13],"nervous":[14],"system.":[15],"Current":[16],"therapies":[17],"lack":[18],"disease-modifying":[20],"potential":[21,164],"and":[22,35,87,97,119,146,149],"precision.":[23],"Astaxanthin":[24],"naturally":[27],"derived":[28],"marine":[29],"compound":[30],"with":[31,92],"potent":[32],"biological":[33],"properties":[34,66],"has":[36],"been":[37],"reported":[38],"to":[39,49,54,59,170],"mitigate":[40],"effects":[42],"of":[43,67,84,108,165],"multiple":[44,85],"sclerosis.":[45],"Herein,":[46],"we":[47,75],"aimed":[48],"develop":[50],"astaxanthin-loaded":[51,98,127,139,166],"gold":[52,69,100,128,141,168],"nanoparticles":[53,101,129,142,169],"enhance":[55],"precision":[56],"in":[57,154,174],"delivery":[58],"brain":[61],"by":[62,115],"efficient":[64],"carrier":[65],"nanoparticles.":[70],"METHODS:":[71],"In":[72],"this":[73,160],"study,":[74],"employed":[76],"an":[77],"experimental":[78],"encephalomyelitis":[80],"(EAE)":[81],"mouse":[82],"model":[83],"treated":[88],"for":[89],"3":[90],"weeks":[91],"free":[93],"astaxanthin":[94],"(6":[95],"mg/kg)":[96],"hollow":[99,140,167],"(0.6":[102],"mg/kg),":[103],"10-fold":[105],"lower":[106],"dose":[107],"drug.":[110],"The":[111],"outcomes":[112,173],"were":[113],"evaluated":[114],"biochemical,":[116],"pathological,":[117],"histological,":[118],"hematological":[120],"parameters.":[121],"RESULTS:":[122],"Our":[123,135],"findings":[124,136],"indicate":[125],"significantly":[130],"improved":[131,143],"disease":[133,156],"outcomes.":[134],"suggest":[137],"oxidative-stress":[144],"indicators":[145],"motor":[147],"deficits":[148],"imparted":[150],"significant":[151],"cellular":[152],"protection":[153],"condition.":[157],"CONCLUSION:":[158],"Overall,":[159],"study":[161],"highlights":[162],"improve":[171],"EAE":[176],"mice":[177],"model.":[178]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}